Skip to main content
Top
Published in: European Journal of Nutrition 5/2019

01-08-2019 | Original Contribution

Pharmacokinetics of vitamin E, γ-oryzanol, and ferulic acid in healthy humans after the ingestion of a rice bran-enriched porridge prepared with water or with milk

Authors: Laura A. Calvo-Castro, Nadine Sus, Christina Schiborr, Anja Bosy-Westphal, Maria Luisa Duran, Doris Fesenmeyer, Gerhard Fesenmeyer, Jan Frank

Published in: European Journal of Nutrition | Issue 5/2019

Login to get access

Abstract

Purpose

In this study, we investigated the absorption and excretion kinetics of antioxidant dietary phytochemicals (vitamin E, γ-oryzanol, and ferulic acid) in healthy humans after the ingestion of an oatmeal porridge supplemented with rice bran extract (RBE) prepared with water or with whole milk, and we compared it with the intake of an equivalent dose of the rice bran content, in the form of RBE oil.

Methods

Twelve healthy volunteers (6 men and 6 women) orally ingested RBE oil (2 g) or RBE-enriched porridge (35 g, including 2-g RBE) with water or with milk, in a three-armed, crossover trial. Blood and urine samples were collected at baseline and up to 24 h after intake. Vitamin E (α-, β-, γ-, and δ-tocopherols and tocotrienols), ferulic acid (FA), and γ-oryzanol (ORY) were quantified by HPLC.

Results

The ingestion of RBE-fortified oatmeal porridge and RBE oil significantly increased FA concentrations in plasma, showing faster absorption and higher maximum plasma concentrations after the intake of the porridges, irrespective of the addition of water or milk. At least part of the FA could have been hydrolyzed from ORY. However, plasma vitamin E concentrations did not increase from baseline, and no intact FA esters (cycloartenyl ferulate, 24-methylenecycloartanyl ferulate, campesteryl ferulate, and β-sitosteryl ferulate) were detected in plasma or urine with any of the meal treatments.

Conclusions

Rice bran extract-enriched porridge and, to a lesser extent, RBE oil, provide relevant sources of bioaccessible and bioavailable ferulic acid, and could be further developed into functional foods with health potential.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization (2016) World Health Statistics 2016: monitoring health for the SDGs, sustainale development goals. In: WHO Press. https://www.who.int. Accessed 18 Apr 2017 World Health Organization (2016) World Health Statistics 2016: monitoring health for the SDGs, sustainale development goals. In: WHO Press. https://​www.​who.​int. Accessed 18 Apr 2017
25.
go back to reference Most MM, Tulley R, Morales S, Lefevre M (2005) Rice bran oil, not fiber, lowers cholesterol in humans. Am J Clin Nutr 81:64–68CrossRefPubMed Most MM, Tulley R, Morales S, Lefevre M (2005) Rice bran oil, not fiber, lowers cholesterol in humans. Am J Clin Nutr 81:64–68CrossRefPubMed
26.
29.
go back to reference Leonard SW, Good CK, Gugger ET, Traber MG (2004) Vitamin E bioavailability from fortified breakfast cereal is greater than that from encapsulated supplements. Am J Clin Nutr 79:86–92CrossRefPubMed Leonard SW, Good CK, Gugger ET, Traber MG (2004) Vitamin E bioavailability from fortified breakfast cereal is greater than that from encapsulated supplements. Am J Clin Nutr 79:86–92CrossRefPubMed
30.
go back to reference Dimitrov NV, Meyer C, Gilliland D et al (1991) Plasma tocopherol concentrations in response to supplemental vitamin E. Am J Clin Nutr 53:723–729CrossRefPubMed Dimitrov NV, Meyer C, Gilliland D et al (1991) Plasma tocopherol concentrations in response to supplemental vitamin E. Am J Clin Nutr 53:723–729CrossRefPubMed
33.
go back to reference Frank J, Lee S, Leonard SW et al (2008) Sex differences in the inhibition of gamma-tocopherol metabolism by a single dose of dietary sesame oil in healthy subjects. Am J Clin Nutr 87:1723–1729CrossRefPubMedPubMedCentral Frank J, Lee S, Leonard SW et al (2008) Sex differences in the inhibition of gamma-tocopherol metabolism by a single dose of dietary sesame oil in healthy subjects. Am J Clin Nutr 87:1723–1729CrossRefPubMedPubMedCentral
39.
go back to reference Brigelius-Flohé R, Kelly FJ, Salonen JT et al (2002) The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 76:703–716CrossRefPubMed Brigelius-Flohé R, Kelly FJ, Salonen JT et al (2002) The European perspective on vitamin E: current knowledge and future research. Am J Clin Nutr 76:703–716CrossRefPubMed
42.
go back to reference Fairus S, Nor RM, Cheng HM, Sundram K (2006) Postprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of α-tocopherol. Am J Clin Nutr 84:835–842CrossRefPubMed Fairus S, Nor RM, Cheng HM, Sundram K (2006) Postprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of α-tocopherol. Am J Clin Nutr 84:835–842CrossRefPubMed
48.
go back to reference Pan Y, Cai L, He S, Zhang Z (2014) Pharmacokinetics study of ferulic acid in rats after oral administration of γ-oryzanol under combined use of Tween 80 by LC/MS/MS. Eur Rev Med Pharmacol Sci 18:143–150PubMed Pan Y, Cai L, He S, Zhang Z (2014) Pharmacokinetics study of ferulic acid in rats after oral administration of γ-oryzanol under combined use of Tween 80 by LC/MS/MS. Eur Rev Med Pharmacol Sci 18:143–150PubMed
Metadata
Title
Pharmacokinetics of vitamin E, γ-oryzanol, and ferulic acid in healthy humans after the ingestion of a rice bran-enriched porridge prepared with water or with milk
Authors
Laura A. Calvo-Castro
Nadine Sus
Christina Schiborr
Anja Bosy-Westphal
Maria Luisa Duran
Doris Fesenmeyer
Gerhard Fesenmeyer
Jan Frank
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 5/2019
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-018-1770-6

Other articles of this Issue 5/2019

European Journal of Nutrition 5/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.